FDA-Inspected Site

China Pharmaceutical University

1 FDA inspection is on record for China Pharmaceutical University in Nanjing, China.

483· Form 483 issued

Nanjing, China · Last updated July 12, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2024-09-20.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 Sep 2024 – 20 Sep 2024Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

20 Sep 2024
21 CFR 211.160(a)

Lab controls established, including changes

Cited by Kejun Cheng, Shelby N Turner

20 Sep 2024
21 CFR 211.180(c)

Records not made readily available to FDA

Cited by Kejun Cheng, Shelby N Turner

20 Sep 2024
21 CFR 211.194(a)

Complete test data included in records

Cited by Kejun Cheng, Shelby N Turner

20 Sep 2024
21 CFR 211.194(d)

Laboratory equipment calibration records

Cited by Kejun Cheng, Shelby N Turner

20 Sep 2024
21 CFR 211.22(a)

Lack of quality control unit

Cited by Kejun Cheng, Shelby N Turner

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(c)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(d)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind China Pharmaceutical University's 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat